Napadisylate salt of a muscarinic M3 antagonist
Details for Australian Patent Application No. 2008212673 (hide)
International Classifications
Event Publications
13 August 2009 PCT application entered the National Phase
PCT publication WO2008/096149 Priority application(s): WO2008/096149
21 April 2011 Alteration of Name
The name of the applicant has been altered to AstraZeneca AB; Pulmagen Therapeutics (Synergy) Limited
28 April 2011 Application Accepted
Published as AU-B-2008212673
25 August 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser